register

Digital & Innovation

First digital platform supporting young Aussies living with incurable movement disorder

Health Industry Hub | April 8, 2021 |

Digital & Innovation: More than 20,000 young Aussies (under 50 years of age) living with an incurable movement disorder are set to benefit from the launch of an Australian-first digital support platform ahead of World Parkinson’s Day (Sunday, April 11, 2021).

Developed as a ‘living lab’ model, the Young Onset Parkinson’s Exchange (YOP-X) is a free-to-download app and resource hub uniquely shaped by the first-hand knowledge and experiences of Australians living with Young Onset Parkinson’s Disease (YOPD).

According to Cognitive Neuroscientist, Founder and CEO, The NeuroTech Institute, and member of The Young Onset Parkinson’s eXchange (YOP-X) project working party, Dr Fiona Kerr, Adelaide, the YOP-X app will prove a critical support tool for those affected by the disease.

“YOPD patients are in the prime of their lives – a time when they should be at their most productive, juggling competing demands, including employment, family and school commitments, sporting, and various social events and activities.

“People living with YOPD must not only face times of debilitating motor impairment, but must also contend with non-motor symptoms, including anxiety, depression, apathy and sleep disorders that can substantially compromise their quality of life.

“The combination of support provided by the YOP-X app and medical care offers YOPD patients a holistic approach to addressing changes involving their work, relationships, sleep, physical ability and mental health,” said Dr Kerr.

Despite the widespread misconception that Parkinson’s Disease only affects older people, one in five of those afflicted actually experience symptoms before 50 years of age, who are classified as living with YOPD. Over the past decade, the incidence of YOPD has increased by 40 per cent, with one Australian diagnosed every three hours.

The YOP-X platform will allow YOPD patients to take greater control of their lives, while also promoting positive behavioural change, explained Research Lead, Wellbeing & Resilience Centre, South Australian Health & Medical Research Institute (SAHMRI), and member of the YOP-X project working party, Mr Joep van Agteren, Adelaide.

“Current data involving Australians living with Parkinson’s under 65 years of age highlights a lack of information, education and understanding of the disease, its symptoms and progression, with a need for greater support and understanding to enhance social, community and economic participation.

“YOP-X provides patients with easily accessible information pertaining to their disease, videos on various topics, including strategies to address their mental health and wellbeing, exercises designed to increase their strength and balance, and a series of educational videos by a Relationship Therapist. The app also offers self-assessment capabilities and issues prompts and reminders to help YOPD patients establish routine in their daily lives, and to push past apathy,” Mr van Agteren said.

After initially disregarding his tremors, attributing them to too much coffee and stress, father-to-two and former school principal, Todd, 39, Adelaide, received a life-changing diagnosis of YOPD at age 35.

“It’s not easy to hear you’ve been diagnosed with what is commonly considered an ‘old person’s disease’, especially when you’re in the prime of your life. An older person diagnosed with Parkinson’s Disease is in a very different stage of life compared to a person living with YOPD. Trying to find information on how the disease might impact my children and family, and the substantial financial implications I was set to face, was very difficult,” said Todd.

Todd, together with other YOPD patients, played a vital role in shaping the development of the YOP-X app tools and resources.

“The YOP-X app, which pulls all of this information together into the one place, will become a go-to resource for people with YOPD. It will further inform this community of patients about their local Parkinson’s Disease organisations, and encourage users to reach out for support.

“Being invited to participate in the YOP-X app focus group was very special to me. We were a group of patients living each day with YOPD, who were tasked with directing what this app would look like, its features, and how far it would reach. YOP-X also equips healthcare professionals and NDIS-contracted providers with the knowledge they require to better meet, and optimally fulfil, the needs of their clients living with neurological degenerative conditions,” he added.

Available to patients, their primary support people (carers), healthcare professionals and NDIS-contracted providers, the YOP-X app can now be downloaded for free from the App Store or Google Play.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.